Trading Ideas Genexine, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 07/05/2024 BST			5-day change	1st Jan Change
7,430 ^KRW	-3.88%		-1.07%	-24.95%

2023	Genexine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Genexine, Inc. and PT Kalbe Genexine Biologics Receives the First Market Approval for Novel Long-Acting Erythropoietin, Efepoetin Alfa, from the Indonesian Food and Drug Authority	CI

No results for this search